Dr Myriam Ouberai

University of Cambridge
MedImmune

University departments
Department of Engineering

Position: Senior Research Associate
Personal home page: http://www.nanoscience.cam.ac.uk/directory/mmo25@cam.ac.uk

PubMed journal articles - click here

Research description

I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to treat challenging diseases such as brain cancer and tuberculosis.
I also joined the NanoForum strategic network of the University of Cambridge as facilitator to foster interdisciplinary research in nanomedicine.
I have worked in collaboration with MedImmune-AstraZeneca since October 2014 to apply cutting-edge research in peptide formulation.
I aim to develop safer and more effective treatments in cancer therapy using targeted drug delivery and combination therapy.

Tiny pieces of gold 'boost brain cancer therapy' in lab
Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma
http://pubs.rsc.org/en/content/articlelanding/2014/nr/c4nr03693j#!divAbs...
http://www.bbc.co.uk/news/health-28754152

 Nanomedicine - drug delivery
 Cancer therapy
 Peptide self-assembly
 Parkinson’s and Alzheimer’s diseases
 Biomolecular engineering
 Protein interaction with lipid membranes
 Proteins at solid-liquid interfaces

Research Programme
Neuro-Oncology
Methods and technologies
Atomic force microscopy
Biosensor
HPLC/FPLC
Protein biochemistry
Tumour type interests
Brain and central nervous system
mmo25
Recent publications:
 Retrieving latest data from feed...

Symplectic Elements feed provided by Research Information, University of Cambridge